SIPAI HEALTH (00314) spent HKD 76,500 to repurchase 50,000 shares on September 3.
Sihai Health (00314) announced that it repurchased 50,000 shares at a cost of HK$76,500 on September 3, 2026, with a buyback price ranging from HK$1.485 to HK$1.54 per share.
SIPAI HEALTH (00314) announced that the company repurchased 50,000 shares on September 3, 2026, for a total of HKD 76,500, at a repurchase price of HKD 1.485-1.54 per share.
Related Articles
Zhejiang Orient Gene Biotech (688298.SH) and its subsidiaries have obtained multiple medical device registration certificates.
BlackRock increased its stake in XIAOMI-W (01810) by approximately 8.3385 million shares, with a per-share price of about HKD 27.62.
KINDSTAR GLOBAL (09960) repurchased approximately 106,500 shares on September 3 at a cost of about HKD 103,100.
Zhejiang Orient Gene Biotech (688298.SH) and its subsidiaries have obtained multiple medical device registration certificates.
BlackRock increased its stake in XIAOMI-W (01810) by approximately 8.3385 million shares, with a per-share price of about HKD 27.62.
KINDSTAR GLOBAL (09960) repurchased approximately 106,500 shares on September 3 at a cost of about HKD 103,100.
RECOMMEND
